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Abstract 
Recruitment of leukocytes from the blood to sites of inflammation poses a promising target for new 
diagnostic and therapeutic approaches. We aimed to develop a novel method to non-invasively analyze 
molecular mechanisms of leukocyte migration in pre-clinical models of inflammation in vivo.  
Methods: We used the ER-HoxB8 system to transiently immortalize murine myeloid precursors from 
wildtype and CD18- as well as MRP14-deficient mice. A VLA4α-/- cell line was generated by 
CRISPR/Cas9-mediated gene editing. We analyzed the migration of wildtype and knockout leukocytes in 
vivo by optical and nuclear imaging in mice with irritant contact dermatitis, cutaneous granuloma, 
experimental arthritis and myocardial infarction. 
Results: Transient immortalization, gene editing and in vivo imaging can be combined to analyze 
migratory mechanisms of murine leukocytes, even for gene deletions resulting in lethal phenotypes in 
mice. We reliably confirmed known migratory defects of leukocytes deficient for the adhesion molecules 
CD18 or VLA4α. Also, using our new method we identified a new role of the most abundant 
calcium-binding proteins in phagocytes and major alarmins in many inflammatory diseases, MRP8 and 
MRP14, for transmigration in vivo. 
Conclusion: We provide a combinatorial approach to rapidly characterize molecular mechanisms of 
leukocyte recruitment in vivo, with the potential to aid in identification of diagnostic and therapeutic 
targets in inflammatory pathologies. 
Key words: Cell migration, Genetic engineering, molecular imaging, leukocytes, MRP8 and MRP14 
Introduction 
Inflammation is the first defense mechanism to 
cope with tissue injury or invading pathogens. 
Uncontrolled inflammation, on the other hand, may 
lead to chronic disorders [1, 2]. Characteristically, 
neutrophils are the first cells to accumulate in 
inflamed tissues [1, 3, 4]. Subsequently, monocytes 
and macrophages play a pivotal regulatory role in the 
promotion but also in the resolution of inflammation 
[1, 3, 5, 6]. Recruitment of phagocytes appears also in 
post-ischemic scenarios such as myocardial infarction 
(MI). While the initial recruitment of monocytes is 
necessary to remove dead cells and initiate the wound 
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healing process, numbers of recruited monocytes in 
the infarct area are frequently too high, impeding the 
resolution of inflammation and thereby worsening 
post-MI prognosis [7–9]. Thus, the sequence and 
dynamics of extravasation of specific phagocyte 
populations to the site of inflammation is a key 
process not only for progression but also resolution of 
inflammation, defining this step as a promising 
therapeutic target to modulate inflammation [10–12]. 
Extravasation of phagocytes occurs via an 
adhesion cascade that involves rolling, arrest, 
crawling and transmigration of cells through the 
endothelial cell (EC) layer to the site of inflammation 
[13]. The relevance of specific adhesion receptors (e.g., 
the integrin β2 (CD18), a subunit of LFA-1 or MAC-1 
binding to ICAM, or integrin α4 (CD49d), a subunit of 
VLA4 binding to VCAM1 [13–15]) has been shown by 
gene mutations and by blocking adhesion molecules 
in mice and man. Although the principal process of 
transmigration is widely accepted, key questions 
remain regarding recruitment of distinct phagocyte 
populations in vivo at specific stages of inflammation 
and in an organ-specific manner. However, 
understanding these mechanisms is a prerequisite for 
the development of innovative diagnostic or 
therapeutic approaches in many clinically relevant 
inflammatory diseases. Addressing these questions is 
difficult due to a wide heterogeneity of ECs in 
different tissues (e.g., blood brain barrier, high 
post-capillary venules). A major obstacle is the lack of 
experimental in vitro setups reliably modeling the 
ample heterogeneity of phagocytes and ECs in 
different organs in vivo. Even sophisticated 
transmigration approaches in vitro cannot reflect the 
biological complexity in vivo. Analysis of genetically 
modified mice is often restricted by lethal or complex 
phenotypes. Still, a reliable and flexible technology 
allowing monitoring of genetically modified leuko-
cytes in clinically relevant models of inflammation in 
mice is lacking. 
Magnetic resonance (MR), nuclear and optical 
imaging provide the possibility to non-invasively 
track the migration of injected cells in mouse models 
in vivo over a longer period of time but depend on 
purification of high numbers of primary leukocytes 
[16–19]. Only limited numbers of monocytes and 
neutrophils are available as circulating blood cells. 
Bone marrow cells, on the other hand, represent a 
very inhomogeneous cell population and purification 
of a specific cell type generally leads to activation or 
differentiation of cells. In addition, genetic 
manipulation of primary phagocytes is not effective 
and is associated with their activation or damage. 
To overcome these challenges, we introduce a 
novel method combining the estrogen-regulated 
ER-HoxB8 system for transient immortalization and 
genetic engineering of murine myeloid precursor cells 
with in vivo imaging. These precursors can easily be 
differentiated to monocytes or neutrophils in high 
quantities [20]. Through the development of fluoresc-
ence reflectance imaging (FRI) and single photon 
emission tomography (SPECT)-based ER-HoxB8 cell 
labeling protocols we are able to quantitatively 
analyze the migration of specific phagocyte 
populations into different organs in the whole body of 
inflammatory animal models. Establishing precursors 
of knockout mice (e.g., CD18-/-) or performing 
targeted genetic modification of ER-HoxB8 cells via 
CRISPR/Cas9 technology (VLA4-/-) uniquely allows 
the analysis of leukocyte migration in genetic 
backgrounds even associated with lethal phenotypes. 
In addition, we describe a new role of the most 
abundant calcium-binding proteins, myeloid related 
protein 8 (MRP8, S100A8) and MRP14 (S100A9), in 
phagocyte transmigration in vivo. MRP8 and MRP14 
represent up to 5-40% of the detergent-soluble 
cytosolic proteins of monocytes and granulocytes, 
respectively [21], but their intracellular actions were 
not well understood so far.  
Our novel technology allows a comparative 
analysis of the migration of wildtype and mutated 
phagocytes in parallel within the same animal. We 
thus describe a method for rapid and almost 
unlimited analysis of migratory properties of 
genetically modified phagocytes in pre-clinically 
relevant settings in vivo for identification and 
confirmation of potential therapeutic anti- 
inflammatory targets in leukocytes. Our approach is 
an easy, quick and reliable alternative for establishing 
genetically modified mouse strains linked with the 
risk of complex or even lethal phenotypes. 
Results 
ER-HoxB8 cell labeling and functional analysis 
For FRI, differentiated ER-HoxB8 monocytes or 
neutrophils were labeled with the fluorescent 
membrane-incorporating dyes DIR or DID. Labeling 
rates were close to 100% (Figure S1C, D) and viability 
was not affected by DIR/DID labeling (more than 
90% viable cells; Figure S1A, B).  
ER-HoxB8 monocytes were labeled with 1.06 ± 
0.2 Bq 111In-Oxine per cell for SPECT experiments. 
Retention of 111In-Oxine in vitro dropped to 74.4% ± 
7.2% after 6 h, 28.3% ± 9.1% after 24 h and 24.8% ± 
3.5% after 48 h (Figure S1E, F). Labeling with 
111In-Oxine did not affect cellular viability (number of 
dead cells below 2%). 
Firstly, ER-HoxB8-derived neutrophils and 
monocytes were confirmed to express typical 
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differentiation markers and exhibit central phagocytic 
functions of the primary counterparts, as described 
previously (Figure S2) [20, 22–24]. In addition, in 
ER-HoxB8 monocytes and neutrophils neither 
adhesion properties (Figure S2B) nor spontaneous 
and chemotactic migration (Figure S2C) nor ROS 
production and phagocytosis (Figure S2D, E) were 
altered due to labeling with DIR or DID. Also 
111In-Oxine-labeled ER-HoxB8 cells did not show 
altered migration rates as compared to unlabeled 
controls (Figure S2F). 
In vivo optical imaging of the migration of 
differentiated ER-HoxB8 cells. 
We used irritant contact dermatitis (ICD) as a 
model of innate immune activation by a non-specific 
toxic stimulus (left ear: application of croton oil, right 
ear: control). DIR-labeled ER-HoxB8 monocytes or 
neutrophils were injected and FRI images were taken 
0-24 h post injection (p.i.). We detected strong and 
significantly higher fluorescence signals in the 
inflamed ear (left) compared to controls (right) for 
monocytes (Figure 1A, B) and neutrophils (Figure 1C, 
D). Due to itching and scratching induced by croton 
oil treatment, mice distribute minor amounts of 
croton oil to the right control ears, inducing a weak 
inflammatory reaction that results in a low backgrou-
nd signal caused by some infiltrating immune cells. 
Injecting ER-HoxB8 LifeAct-EGFP monocytes, we 
confirmed infiltration of viable monocytes in situ by 
anti-GFP staining in histological sections (Figure 1E). 
Immigrated labeled ER-HoxB8 neutrophils and 
monocytes could also clearly be detected in 
histological sections of inflamed ears using the 
LI-COR® Odyssey® Imaging system (Figure 1F).  
We also analyzed ER-HoxB8 cell migration in 
experimental arthritis as a clinically relevant model of 
autoimmunity. In collagen-induced arthritis (CIA), 
we could detect infiltrating DIR-labeled monocytes in 
inflamed paws (CIA disease score ≥2). Control 
animals showed nearly no signal (Figure 2A-C). A 
significant association of individual fluorescence 
signals (immigrating ER-HoxB8 cells) and disease 
scores (“clinical” degree of inflammation) could be 
found. Also, in IL1-Ra-/- mice, which spontaneously 
develop arthritis due to overwhelming innate 
immune activation, labeled ER-HoxB8 GFP 
monocytes infiltrated inflamed joints (Figure 2D). 
α-GFP staining of histological sections confirmed 
infiltration of viable ER-HoxB8 cells (Figure 2E).  
In vivo imaging of ER-HoxB8 cells by combined 
nuclear and optical imaging. 
In order to analyze defined inflammatory 
triggers, we employed a cutaneous granuloma model 
(CG), in which two biogel “plugs” were injected into 
the right (control) and the left flank (addition of LPS), 
triggering Toll-like receptor 4-dependent inflamm-
ation. In vivo FRI showed highly significant 
differences between cellular infiltration into control 
and LPS plugs between 0-48 h after injection of 
DIR-labeled ER-HoxB8 monocytes (Figure 3A, B). 
After re-isolation of immigrated cells out of the plugs, 
we found a viable population of positive cells 
(DIR/DID+) by flow cytometry representing about 
2-10% of the total amount of immigrated cells (Figure 
3C). 
Though FRI is a relatively easy, fast and catchy 
method for investigating cell migration, it neverth-
eless has limitations. Regarding the penetration depth 
of tissue or 3D resolution, FRI is clearly outnumbered 
by SPECT or MRI. Additionally, SPECT allows the 
non-invasive, body-wide assessment of injected cells 
at early time points. We labeled ER-HoxB8 monocytes 
radioactively with 111In-Oxine and tracked their 
biodistribution by serial SPECT imaging in healthy 
mice. Labeled cells accumulated in the lungs for the 
first 90 min, before being redistributed to spleen, liver 
and bone. Non-retained radioactivity was eliminated 
via the kidneys (Figure S3).  
To confirm the applicability of 111In-Oxine- 
labeled ER-HoxB8 monocytes for in vivo tracking in 
inflammation FRI as well as SPECT measurements 
were carried out in parallel in the same animals. 
Finally, cell migration into the biogel plugs was 
determined by ex vivo scintillation counting and 
optical imaging. For both approaches, immigrated 
ER-HoxB8 monocytes could be detected to a 
significantly higher extent in LPS plugs compared to 
controls (Figure 3D, E) and time courses of signal 
accumulation in both techniques fit very well to each 
other (Figure 3F, G). In contrast to FRI, three- 
dimensional SPECT acquisitions allowed detection of 
immigrated cells not only at the surface of the plug, 
but in deeper tissues, specifically at the inner border 
of the biogel plug (Figure 3E). The higher in vivo 
signal from 111In-Oxine-labeled cells in control PBS 
plugs reveals the higher sensitivity of SPECT 
compared to FRI.  
Simultaneous in vivo FRI analysis of the 
migration of different cell populations. 
In the next step, we simultaneously injected 
ER-HoxB8 wildtype (wt) monocytes labeled with DIR 
and ER-HoxB8 CD18-/- monocytes labeled with DID, 
two spectrally distinct fluorophores, into the CG 
model. This approach allows direct comparison of the 
migration behaviors of two monocyte populations in 
the same animal in vivo, at the same time reducing the 
number and experimental variations between indivi-
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dual animals per experimental setup. FRI measure-
ments were adjusted for differences in labeling 
efficiencies and corrected for spectral overlap of DIR 
and DID. CD18-/- was chosen as an example based on 
its important role in phagocyte migration [13, 25]. 
Compared to DIR-labeled ER-HoxB8 wildtype 
monocytes, DID-labeled ER-HoxB8 CD18-/- mono-
cytes exhibited significantly decreased infiltration 
rates reflected by low FRI signals. Overall recruitment 
of CD18-/- monocytes into the inflammation site was 
reduced by about 75% (Figures 4C, D).  
 
 
Figure 1: In vivo optical imaging of monocyte and neutrophil migration in an ear inflammation model (irritant contact dermatitis, ICD). 
ER-HoxB8 wildtype (wt) monocytes/neutrophils were labeled with DIR and injected i.v. in a mouse showing inflammation at the left ear (right ear served as internal 
control) due to ICD induction 24 h before. FRI images were taken 0 h, 1 h, 3 h, 6 h and 24 h p.i. (A) Representative imaging series 0-24 h p.i. showing DIR-labeled 
monocyte infiltration into inflamed tissue by fluorescence signal accumulation. (B) Statistical analysis of immigration of labeled ER-HoxB8 monocytes into inflamed 
tissue (left ear) as compared to control (right ear) (n=15 mice, 5 independent experiments). (C) Representative imaging series 0-24 h p.i. showing DIR-labeled 
neutrophil infiltration into inflamed tissue. (D) Statistical analysis of immigration of labeled ER-HoxB8 neutrophils into inflamed tissue (left ear) as compared to control 
(right ear) (n=15 mice, 5 independent experiments). (E) ER-HoxB8 EGFP monocytes were used for cell tracking and immunolocalized on frozen sections of inflamed 
tissue by α-GFP/peroxidase staining. Arrows indicate cells positive for α-GFP staining. (F) Frozen sections of inflamed/control ears. Black spots indicate immigrated 
DIR/DID labeled cells. Images orientation: L = left, R = right, fluorescence = fluorescence intensity (AU). Data are shown as dotplots with mean ± SEM, corrected to 
baseline and labeling efficiency. Statistical significance was calculated using paired Student’s t-test: *p < 0.05, **p < 0.01, ***p < 0.001. 
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Figure 2: In vivo optical imaging of monocyte migration in experimental arthritis. ER-HoxB8 wildtype monocytes were labeled with DIR and injected i.v. 
in (A-C) a CIA mouse showing joint inflammation with severe disease score and a healthy control mouse. FRI images were taken 0 h, 1 h, 3 h, 6 h and 24 h p.i. (D-E) 
Labeled ER-HoxB8 monocytes were injected i.v. in an IL-1Ra-/- mouse with severely inflamed joints. A FRI image was taken 24 h p.i. (A) Representative imaging series 
of control and CIA mouse (0-24 h) indicating monocyte infiltration into inflamed tissue. (B) Stereomicroscopic images of paws corresponding to (A). (C) Statistical 
analysis of immigration of ER-HoxB8 monocytes into uninflamed or mildly inflamed (score 0 and ≤ 1) paws as compared to severely inflamed (score >2) paws (n=48 
paws, 3 independent experiments). (D) Representative image of IL-1Ra-/- mouse (24 h) indicating monocyte infiltration by fluorescence signal accumulation. (E) 
ER-HoxB8 GFP monocytes were used for cell tracking and immunohistological localization of GFP positive cells was performed on frozen sections of inflamed ankle 
joints by α-GFP staining. Arrows indicate cells positive for α-GFP staining. Images orientation: L = left, R = right, fluorescence = fluorescence intensity (AU), ds = 
disease score. Data are shown as dotplots with mean ± SEM, corrected to baseline and labeling efficiency. Statistical significance was calculated using Kruskal-Wallis 
analysis and Dunn’s Multiple Comparison Test: *p < 0.05, **p < 0.01, ***p < 0.001. 
 
To confirm the accuracy of the simultaneous 
injection protocol of two labeled monocyte 
populations, we studied single cell injections of 
DIR-labeled wildtype or CD18-/- monocytes separately, 
which tightly reproduced the results of the 
experiments with simultaneous injection of two 
monocyte populations (Figures 4A, B). Knockout of 
CD18-/- cells was confirmed by qRT PCR of mRNA 
and flow cytometry analysis (Figure 4E, F). 
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Figure 3: In vivo imaging of monocyte migration in a cutaneous granuloma (CG) model combining optical (FRI) and nuclear (SPECT) imaging 
technique. (A-C) ER-HoxB8 DIR-labeled wildtype monocytes were injected i.v. in a CG mouse model (left 20 µg/mL LPS, right plug served as control). FRI images 
were taken 0-48 h p.i. (A) Representative imaging series showing monocyte immigration. (B) Statistical analysis of migration of ER-HoxB8 monocytes to LPS plug as 
compared to control plug (n=14 mice, 5 independent experiments). (C) Representative flow cytometry analysis of re-isolated cells from plugs; FL4-H corresponds to 
DIR/DID-labeling. Representative pseudocolor plots of viable cells (dead cells discriminated by FSC/SSC gating) depicted. (D-G) ER-HoxB8 monocytes were labeled 
with DIR or 111In-Oxine and were simultaneously injected i.v. in the same animal. FRI and SPECT measurements were taken 6-48 h p.i. (D) Representative imaging 
series showing DIR-labeled monocyte migration to LPS plug and (E) corresponding SPECT images of the same animal showing surface signals from 111In-Oxine-labeled 
monocytes (arrowhead) and additional deep tissue signals (arrow). (F) Statistical analysis of migration of DIR-labeled monocytes to LPS plug as compared to control 
plug (n=6 mice, 2 independent experiments). (G) Statistical analysis of migration of 111In-Oxine-labeled monocytes to LPS plug as compared to control plug (n=6 mice, 
2 independent experiments) corresponding to (F). Images orientation: L = left, R = right, fluorescence = fluorescence intensity (AU). Data are shown as dotplots with 
mean ± SEM, corrected to baseline and labeling efficiency for DIR labeling and displayed as SUV (standardized uptake units) for 111In-Oxine labeling. Statistical 
significance was calculated using paired Student’s t-test: *p < 0.05, **p < 0.01, ***p < 0.001.  
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Figure 4: In vivo optical imaging of wt and CD18-/- monocyte migration in a CG model. ER-HoxB8 wildtype and CD18-/- monocytes were labeled with DIR 
and each cell population was injected in an individual animal (A-B). Alternatively, ER-HoxB8 wildtype and CD18-/- monocytes were differentially labeled with DIR and 
DID and injected in the same mouse (C-D). FRI images were taken 0 h, 3 h, 6 h, 24 h, 30 h and 48 h p.i. (A) Representative imaging series of the one color imaging 
approach in two individual mice 3-48 h p.i. Upper panel shows LPS plug infiltration of wt monocytes (DIR). Lower panel shows LPS plug infiltration of CD18-/- 
monocytes (DIR). (B) Statistical analysis of imaging of wt and CD18-/- cell migration to LPS plug corresponding to (A) (n=8 mice, 3 independent experiments). (C) 
Representative imaging series of the two color simultaneous imaging approach in a single mouse 3-48 h p.i. Upper panel shows LPS plug infiltration of wt monocytes 
(DIR). Lower panel shows LPS plug infiltration of CD18-/- monocytes (DID). (D) Statistical analysis of simultaneous imaging of wt and CD18-/- cell migration to LPS plug 
corresponding to (C) (n=9 mice, 3 independent experiments). (E-F) Verification of CD18 knockout in ER-HoxB8 CD18-/- monocytes. Representative results are 
shown. (E) Result of qRT-PCR of wt (day 0 and day 3) compared to CD18-/- monocytes for CD18 mRNA. (F) Flow cytometry analysis of α-CD18 staining of wt and 
CD18-/- monocytes (day 3). Expression of CD18 was detected as FL2-H+. Open graphs show isotype control; grey graphs show α-CD18 staining. Images orientation: 
L = left, R = right, fluorescence = fluorescence intensity (AU). Data are shown as dotplots with mean ± SEM, corrected to baseline and labeling efficiency. Statistical 
significance was calculated using 2-way ANOVA and Bonferroni post-tests comparing ER-HoxB8 wildtype and CD18-/- cells: *p < 0.05, **p < 0.01, ***p < 0.001.  
 
In order to test our method for knockouts 
resulting in complex or lethal phenotypes in vivo we 
combined our approach of ER-HoxB8 cell tracking 
with innovative gene editing techniques, like the 
clustered regularly interspaced short palindromic 
repeats/caspase 9 (CRISPR/Cas9) system, allowing 
for specific and efficient editing of genes [26]. We 
therefore employed CRISPR/Cas9 in ER-HoxB8 cells 
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to delete the integrin α4 subunit of VLA4, which is 
known to play a role in phagocyte recruitment but 
creates a lethal phenotype in mice [13, 25, 27]. VLA4 
knockout was confirmed by qRT PCR of mRNA, flow 
cytometry and DNA sequencing (Figure 5E-G). We 
simultaneously analyzed and tracked DIR-labeled 
ER-HoxB8 wildtype and DID-labeled ER-HoxB8 
VLA4α-/- monocytes in the CG model. ER-HoxB8 
VLA4α-/- monocytes exhibited a major migratory 
defect. In “two color simultaneous imaging” 
experiments we found a significant reduction of about 
50% for ER-HoxB8 VLA4α-/- monocytes compared to 
ER-HoxB8 wildtype monocytes (Figure 5A, B). Using 
DID-labeled ER-HoxB8 wildtype and DIR-labeled 
ER-HoxB8 VLA4α-/- monocytes in this setting yielded 
comparable results (data not shown). Applying one 
color imaging we observed a reduction of cell 
migration by about 55% for ER-HoxB8 VLA4α-/- 
compared to ER-HoxB8 wildtype monocytes (Figure 
S4A, B). 
Calcium binding proteins MRP8 and MRP14 
were previously found to interact with tubulin under 
inflammatory conditions, thereby regulating cytoskel-
etal dynamics of phagocytes in vitro [28, 29]. However, 
biological relevance of these findings could not be 
confirmed so far in vivo. We used DIR-labeled 
ER-HoxB8 wildtype monocytes and DID-labeled 
ER-HoxB8 MRP14-/- monocytes and compared the 
migratory capacities of both cell types by “two color 
simultaneous imaging” in the CG mouse model. We 
found MRP14-/- cell migration decreased by about 
50% at 6 h p.i. and by 40% at 24 h p.i., indicating a 
significant delay in MRP14-/- monocyte recruitment 
as compared to wildtype monocytes (Figure 5C, D). 
MRP14 knockout in MRP14-/- cells was confirmed by 
qRT PCR of mRNA and Western Blot (WB) analysis 
(Figure 5H, I).  
In vivo nuclear imaging of monocyte migration 
in myocardial infarction (MI) 
We applied SPECT to assess the migration of 
monocytes in the clinically relevant disease scenario 
of MI. This model comprises major challenges for in 
vivo imaging, i.e., detection of small numbers of 
infiltrating monocytes in a deep and rapidly moving 
organ (450 beats per minute). 111In-Oxine-labeled 
monocytes were intravenously administered to mice 
with permanent MI one day after coronary artery 
ligation and their migration was followed by serial 
SPECT imaging. Areas at risk were determined on the 
day of the surgery by 99mTc-Tetrofosmin SPECT to 
define the extension of perfusion defects and signal 
from 111In-Oxine-labeled monocytes was quantified 
one and two days p.i. (Figure 6A). The SPECT signal 
within the infarct zone (I) was significantly increased 
compared to remote myocardium (R) on both days (I: 
0.60 ± 0.07 SUV vs. R: 0.37 ± 0.02 SUV on day 1 and I: 
0.47 ± 0.04 SUV vs. R: 0.25 ± 0.03 SUV on day 2).  
Ex vivo autoradiography detected 111In-Oxine- 
labeled cells in areas showing large amounts of 
infiltrated monocytes by immunohistochemistry 
(Figure 6B). We confirmed signal specificity by 
application of free 111In-Oxine in MI mice or 
application of 111In-Oxine-labeled monocytes in sham 
operated animals (Figure S5). 
Discussion 
The ability to investigate phagocyte migration 
under clinically relevant inflammatory conditions in 
vivo poses an unmet challenge in translational 
biomedical research for the development of novel 
diagnostic assays or therapeutic targets. Current 
experimental approaches exhibit major limitations for 
modeling the complex processes of leukocyte recruit-
ment due to the high heterogeneity of leukocytes and 
ECs. Combining reversible immortalization of 
myeloid progenitors with modern gene editing 
techniques and in vivo imaging technologies, we now 
present a novel approach that allows quantitative 
analysis of leukocyte transmigration combined with 
genetic interventions in complex preclinical inflame-
matory models in mice.  
We established an efficient labeling method for 
ER-HoxB8-derived neutrophils and monocytes 
resulting in high numbers of labeled cells, which is 
currently not achievable with other methods for the 
generation of murine phagocytes. Exogenous cell 
labels, as used here for both imaging strategies, 
comprise the advantage of flexibility as they can easily 
be applied to all cell types. Endogenous labels, in 
contrast, require time-consuming transfection with 
genetic imaging reporters or even complex and 
labor-intensive generation of genetically modified 
mice. On the other hand, cells expressing reporter 
constructs can be repeatedly followed up in vivo over 
a longer period of time. Applying our combination of 
genome editing and HoxB8-induced immortalization 
on a genetic background expressing a reporter 
construct may finally combine all advantages of these 
individual methods [18, 30].  
Pure populations of monocytes or neutrophils 
are not available from primary mouse sources in 
quantities sufficient for in vivo imaging. Bone marrow 
cells, which have been used alternatively, comprise a 
broad spectrum of cells and cell subtypes. 
Furthermore, bone marrow-derived or peritoneal 
macrophages represent later differentiation stages not 
relevant for transendothelial migration studies. As 
previously described, the ER-HoxB8 cell system 
allows for the generation of the required quantities of 
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myeloid cells while resembling major characteristics 
of primary monocytes or neutrophils as shown by 
morphology, differentiation markers, functional 
assays and even genome-wide gene expression 
analysis [20, 22–24, 31–33]. Still, even after withdrawal 
of estrogen, ER-HoxB8-derived phagocytes are 
retrovirally transduced cells despite their behavior, 
which seems similar to primary immune cells. Our 
labeled cells showed a homogenous differentiation, a 
normal functionality and a high viability and 
migratory capacity in vitro. We demonstrate for the 
first time that this cell system is a feasible technique 
for monitoring murine neutrophil and monocyte 
trafficking during inflammation in vivo, independent 
of the underlying immunological pathomechanism. 
We got reliable results in a variety of pre-clinical 
models reflecting toxic and TLR4-mediated innate 
immune responses in the skin, complex autoimmune 
diseases like arthritis involving phagocytes, T- and 
B-lymphocytes or ischemia-induced tissue injury. We 
confirmed infiltration of viable labeled monocytes 
and neutrophils by immunohistochemistry and ex vivo 
analysis. In our arthritis model we could even show a 
close correlation between clinical disease scores and 
monocyte immigration, demonstrating that our 
method is a powerful tool for monitoring leukocyte 
recruitment and severity of inflammation in 
preclinical murine models of arthritis. 
Using two dyes with different excitation/ 
emission spectra we further succeeded in direct and 
quantitative comparison of the migration character-
ristics of cells with two different genetic backgrounds. 
We found CD18-/- monocytes exhibiting highly 
decreased migration rates compared to wildtype 
controls. Since ER-HoxB8 cells can easily be 
established for any existing knockout mouse line, our 
method now allows functional analysis of migratory 
capacities of a myriad of genetically modified 
leukocytes. To further overcome restrictions like lack 
of an appropriate knockout mouse strain or lethal 
knockout phenotypes, we combined our approach 
with the CRISPR/Cas9 system for modifying 
ER-HoxB8 cells [20, 26]. We have chosen VLA4α 
(CD49d), the integrin α4 subunit of VLA4, which is 
involved in the leukocyte adhesion cascade where it 
primarily mediates arrest of phagocytes by binding to 
VCAM [13]. Knockout of integrin α4 in mice leads to a 
lethal phenotype impeding generation of ER-HoxB8 
VLA4α-/- cells [27]. However, using CRISPR/Cas9 we 
demonstrate that ER-HoxB8 VLA4α-/- monocytes 
revealed significantly decreased migration rates 
compared to controls. Addressing two central 
adhesion molecules of the integrin family, CD18 (vital 
phenotype) and CD49d (lethal phenotype) we clearly 
demonstrate the feasibility of our novel approach for 
functional analysis of leukocyte migration in vivo [13, 
25, 27]. Thus, we have an easy and feasible technique 
to model any clinically relevant mutation found in 
patients with innate immune deficiencies for 
mechanistic studies and testing therapeutic 
approaches. 
Finally, we analyzed the migratory capacity of 
ER-HoxB8 MRP14-/- monocytes. In contrast to CD18 
or CD49d, which were extensively described as part 
of the migratory network before, evidence for an 
intracellular role of MRP8/14 during phagocyte 
migration in vivo was lacking [28]. We could now 
demonstrate that knockout of the major 
calcium-binding protein in phagocytes, MRP14, led to 
a significant reduction of cell migration. MRP14 and 
its binding partner MRP8 represent the major 
calcium-binding capacity in granulocytes and 
monocytes [34]. They play a dominant role in many 
clinically relevant inflammatory diseases like 
rheumatoid arthritis, inflammatory bowel disease, 
lung disease, infections, sepsis, allergies or 
autoimmune diseases [35–41]. Hence, this is a 
prototypic example for identification of the relevance 
of complex and non-obvious phenotypes in vivo that 
could serve as a blueprint for analysis of almost any 
molecular system in phagocytes using this new 
approach in preclinical models in vivo.  
Hence, the combination of ER-HoxB8 cells and 
genetic engineering via CRISPR/Cas9 in principle 
facilitates the generation of any conceivable knock-out 
in monocytes or neutrophils, which altogether takes 
only weeks or a few months before in vivo 
experiments can be started. Establishment of a 
conditional knock-out strain for complex or lethal 
phenotypes, on the other hand, crossing with 
cell-specific or inducible Cre-mice and final 
back-cross with adequate reporter mouse strains will 
take at least one or two years. With a few 
modifications, this approach may also be feasible for 
other stem cell models. Introduction of specific 
gain-of-function mutations is another option of the 
CRISPR/Cas9 technology. The combination of 
genetically targeted ER-HoxB8 neutrophils or 
monocytes with the cutaneous granuloma model now 
allows molecular analysis of any combination of a 
genetic mutation in the leukocyte (e.g., adhesion or 
chemokine receptor, signaling molecule, transcription 
factor) and any inflammatory trigger in the 
granuloma (microbial products, cytokines, chemoki-
nes or alarmins) in vivo. In addition, differences 
regarding the biological relevance of specific adhesion 
and signaling pathways can be analyzed for different 
tissues and mechanisms of inflammation. 
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Figure 5: In vivo optical imaging of VLA4α-/- and MRP14-/- monocyte migration in a CG model. ER-HoxB8 wildtype and VLA4α-/- monocytes (A-B) or 
wildtype and MRP14-/- monocytes (C-D) were differentially labeled with DIR or DID and injected in the same mouse. FRI images were taken 0 h, 3 h, 6 h, 24 h, 30 h 
and 48 h p.i. (A and C) Representative imaging series (3-48 h) of two color simultaneous imaging of LPS plug infiltration in a single mouse is shown for (A) wt 
monocytes (DIR, upper panel) and VLA4α-/- monocytes (DID, lower panel) and (C) wt monocytes (DIR, upper panel) and MRP14-/- monocytes (DID, lower panel). (B 
and D) Statistical analysis of simultaneous imaging of cell migration to LPS plug of (B) wt and VLA4α-/- monocytes corresponding to (A) (n=8 mice, 3 independent 
experiments) and (D) of wt and MRP14-/- monocytes corresponding to (C) (n=12 mice, 5 independent experiments). (E-G) Verification of VLA4α (CD49d) knockout 
in ER-HoxB8 VLA4α-/- monocytes. Representative results are shown. (E) qRT-PCR of wt and VLA4α-/- monocytes (day 3) for CD49d (VLA4α) mRNA. (F) Flow 
cytometry analysis of α-CD49d staining of wt and VLA4α-/- monocytes (day 3). CD49d expression was detected as FL2-H+. Open graphs show isotype control; grey 
graphs α-CD49d/VLA4α staining. (G) DNA-sequencing of the CRISPR/Cas9 target region of VLA4α-/- monocytes. (H-I) Verification of MRP14 knockout in ER-HoxB8 
MRP14-/- monocytes. Representative results are shown. (H) qRT-PCR of wt and MRP14-/- monocytes (day 0 and day 3) for MRP14 mRNA. (I) WB analysis of wt and 
MRP14-/- monocytes (day 3) by α-MRP14 staining. Images orientation: L = left, R = right, fluorescence = fluorescence intensity (AU). Data are shown as dotplots with 
mean ± SEM, corrected to baseline and labeling efficiency. Statistical significance was calculated using 2-way ANOVA and Bonferroni post-tests comparing ER-HoxB8 
wildtype and VLA4α-/- or MRP14-/- cells: *p < 0.05, **p < 0.01, ***p < 0.001.  
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Figure 6: In vivo nuclear imaging of monocyte migration in murine myocardial infarction. ER-HoxB8 wildtype monocytes were labeled with 111In-Oxine 
and injected 1 day after permanent coronary artery ligation. (A) Representative images showing myocardial perfusion deficit in 99mTc-Tetrofosmin SPECT acquisitions 
(red VOI) below the coronary artery ligation site (arrowhead). Accumulation of 111In-Oxine-labeled monocytes 1 and 2 days post cell injection in the infarct (arrow) 
and at sites of surgery-induced thorax inflammation (#). (B) Verification of monocyte migration by ex vivo autoradiography, detecting 111In-Oxine-labeled monocytes 
in the infarct zone (dotted line), which presents with high numbers of infiltrated macrophages, visualized by Mac-3 staining. (C) Statistical analysis of monocyte 
migration detected by in vivo SPECT (n= 5 mice, 3 independent experiments). Images orientation: L = left. Data are shown as dotplots with mean ± SEM. SUV: 
standardized uptake units; %ID/mL: % injected dose per volume. Statistical significance was calculated using 2-way ANOVA and Bonferroni post-test: *p < 0.05, **p 
< 0.01, ***p < 0.001. 
 
A remaining issue one may quote is the low 
tissue penetration depth of FRI, excluding organs like 
lung and heart from being analyzed [18]. Concerning 
this matter, we successfully used a SPECT-based 
imaging approach and showed an excellent 
correlation between results obtained by FRI and 
SPECT. We thus expanded our approach for 
quantitative analysis of cell migration in complex 
disease models affecting deeper tissues and proved 
this by successfully tracking 111In-Oxine-labeled 
monocytes in myocardial infarction. 
The huge heterogeneity of endothelial cells in 
different tissues requires new approaches addressing 
molecular mechanisms of phagocyte transmigration 
in vivo. Recent advances in intravital high-resolution 
microscopy have allowed direct visualization of 
phagocyte recruitment to sites of infections or injury 
in vivo and revealed differences in phagocyte 
recruitment between different tissues [30, 42–47].  
Intravital microscopy studies have revealed 
novel insights into self-organized neutrophil 
recruitment to wounds or infectious sites, and how 
danger molecules guide phagocytes to sites of sterile 
inflammation [42, 45]. 
These techniques are, however, restricted to a 
small field-of-view, are very sensitive to tissue motion 
(e.g., heartbeat, respiration), and need invasive 
preparation of tissues, which may be associated with 
the risk of experimental artefacts. However, 
combining these innovative microscopic imaging 
methods with the genome-editing technique of 
HoxB8-derived phagocytes described here may also 
be a promising approach to study molecular 
mechanisms of phagocyte recruitment. Whole body 
imaging approaches like FRI or SPECT do not have 
nearly the spatial resolution of microscopic 
techniques but have the potential for quantification of 
dynamic leukocyte recruitment not only in a specific 
inflammatory site but at the same time in all other 
organs of an organism in complex inflammatory 
scenarios [18, 44].  
In summary, we present a novel, reliable but 
nevertheless rapid and simple method that opens 
almost unlimited possibilities for analysis of 
phagocyte migration in pre-clinical models in vivo, 
including targeted modification of phagocyte-specific 
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molecular pathways during adhesion and 
transendothelial migration. We present an easy, quick 
and reliable alternative for the time consuming 
establishment of genetically modified mouse strains 
for analysis of phagocyte recruitment in vivo. Our 
approach opens multiple capabilities for testing 
diagnostic or therapeutic hypotheses at the molecular 
level in inflammatory processes under clinically 
relevant conditions. 
Methods 
Animals 
C57 BL/6 mice were obtained from Harlan 
laboratories, Borchen, Germany, or Charles River, 
Erkrath, Germany, and DBA/jdba1/j mice from 
Janvier, Le Genest-Saint-Isle, France. IL-1Ra-/- mice on 
BALB/c background were kindly provided by Dr. M. 
Nicklin (Sheffield, UK) and were generated as 
described previously [48]. Animals were used at the 
age of 8–12 weeks and were sex matched for each set 
of experiments. All experiments with mice were 
performed with the approval of the State Review 
Board of Nordrhein-Westfalen (Germany) according 
to the German law for animal welfare or by the Ethics 
Committee of University Hospital Nijmegen. Animal 
studies were not randomized or blinded. 
Generation and cell culture of ER-HoxB8 cells 
ER-HoxB8 cells were generated as previously 
described [20]. In summary, bone marrow cells were 
isolated from wildtype as well as CD18-/- and MRP14-/- 
C57 BL/6 mice by density gradient centrifugation, 
and cultured for 2-3 days in DMEM with 15% FCSi, 
1% penicillin/streptomycin, 1% L-glutamine 
(Biochrom, Berlin, Germany) and containing IL-3 (10 
ng/mL; PeproTech Rocky Hills, USA), IL-6 (20 
ng/mL; PeproTech, Rocky Hills, USA) and SCF (25 
ng/mL; supernatant SN’ from SCF-producing CHO 
cells, Institute of Microbiology and Hygiene, 
Freiburg). Subsequently, cells were transfected with 
ER-HoxB8 Retrovirus (1 mL of virus 
suspension/1x106 cells, kindly provided by the 
Häcker lab) and exposed to spinoculation in the 
presence of lipofectamine (Lipofectin® Transfection 
reagent, Invitrogen, Darmstadt, Germany). Selection 
of transduced, i.e., immortalized, progenitor cells was 
carried out by cultivation of cells in either Optimem 
Glutamax (Gibco Invitrogen, Darmstadt, Germany) 
with 10% FCSi, 1% pen/strep, 30 µM 
ß-mercaptoethanol, 1% SN’ SCF, and 1 µM ß-estradiol 
(Sigma Aldrich, Munich, Germany) for neutrophilic 
progenitor cells or RPMI1640 (Merck Millipore, 
Darmstadt, Germany) with 10% FCSi, 1% pen/strep, 
1% L-glutamine, 1% SN GM-CSF (obtained from B16 
cells, Institute of Microbiology and Hygiene, 
Freiburg), and 1 µM ß-estradiol for monocytic cells. 
Cells were routinely tested for mycoplasma 
contamination. 
For differentiation of precursors to neutrophils 
or monocytes, cells were harvested, washed twice 
with PBS containing 10% FCSi and 1% SN’ SCF or SN’ 
GM-CSF to remove ß-estradiol and seeded at densities 
of 1x106 cells/mL in either Optimem Glutamax with 
10% FCSi, 1% pen/strep, 30 µM ß-mercaptoethanol, 
and 1% SN’ SCF to obtain neutrophils or RPMI1640 
with 10% FCSi, 1% pen/strep, 1% L-glutamine, and 
0.04 µg/mL rm GM-CSF (Immunotools, Friesoythe, 
Germany) for monocytes, respectively. After 3 days of 
differentiation, cells were harvested and assigned to 
experiments. Differentiation to neutrophils and 
monocytes was confirmed by expression of 
differentiation markers CD11b, CD14 and GR-1 by 
flow cytometry. Knockout of CD18-/- cells was 
routinely tested by flow cytometry using 
α-mouse-CD18 (#101401, Biolegend, San Diego, USA) 
and goat-α-rat IgG PE (#112-116-143, Dianova, 
Hamburg, Germany) and by qRT PCR (Primer fw: 
5’-tctcctactccatgcttgatgacc-3’, rv: 5’-aaacgacccaaagccga 
tg -3’). Knockout of MRP14-/- cells was tested by qRT 
PCR (Primer fw: 5’-ggcaaaggctgtgggaagt-3’, rv: 
5’-ccattgagtaagccattcccttta-3’) and Western blot 
analysis using α-mouse-MRP14 [49] and goat-α-rabbit 
IgG HRP (#P044801-2, Agilent, Santa Clara, USA).  
Generation of ER-HoxB8 GFP+ cells 
A lentiviral vector for GFP was produced as 
described previously [50]. Virus concentrations were 
determined with the INNOTEST HIV antigen mAb kit 
(DiaSorin, Saluggia, Italy) and expressed as 
nanograms of p24GAG per microliter. ER-HoxB8 cells 
were transduced with 50 ng virus/5x104 cells in 
complete medium (+ 8 µg/mL Polybrene (Sigma- 
Aldrich, Munich, Germany)). Afterwards, ER-HoxB8 
cells were cultured with standard culture medium. 
Transduction efficiency was around 70% as 
determined by flow cytometry analysis. 
Generation of ER-HoxB8 VLA4α-/- cells via 
CRISPR/Cas9 
ER-HoxB8 VLA4α-/- cells were generated via the 
CRISPR/Cas9 system of genome editing as described 
earlier [26, 51, 52]. 
Briefly, a guide RNA (gRNA) was determined, 
containing the target sequence for VLA4α (CD49d) 
and the cutting sequence for BsmBI (fw: 5´-caccga 
tccacatatatgtaacct-3´, rv: 5´-aaacaggttacatatatgtggatc 
-3´) allowing for the insertion of gRNA into 
lentiCRISPRv2 plasmid (Addgene, Cambridge, USA, 
Nr. 52961) after hybridization and phosphorylation of 
oligos. Plasmids were then transformed in 
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DH5α-competent bacteria (ThermoFisher Scientific, 
Waltham, USA), incubated o/n and a mini-prep was 
inoculated the next day and prepared 24 h later. DNA 
was subsequently assigned for sequencing.  
For virus propagation, HEK cells were split to 
1.5x105 cells/mL and transfected the next day at 70% 
confluency with the lentiCRISPRv2gRNA transfer 
plasmid + packaging plasmid (psPAX2) + envelope 
plasmid (pCMV-VSV-G) in a 2:2:1 proportion. 48 h 
after transfection, the virus-containing supernatants 
were harvested and used for transduction of 
ER-Hoxb8 cells. 
ER-HoxB8 monocytic wildtype cells were seeded 
at 3x105 cells/mL, infected and exposed to 
spinoculation in the presence of polybrene (8 µg/mL). 
Cells were then cultivated for 2 weeks as described. 
Selection of transduced cells started 3 weeks post 
infection by the addition of puromycin (InvivoGen, 
San Diego, USA) to the culture medium as the 
lentiCRISPRv2 plasmid comprises puromycin 
resistance. Lethal concentration of puromycin for 
wildtype cells was determined beforehand. 
After two weeks of continuous selection, cells 
were tested for knockout of VLA4α by flow cytometry 
analysis using α-mouse-CD49d (#01271D, Pharmin-
gen, BD Biosciences, San Jose, USA) and goat-α-rat 
IgG PE (#112-116-143, Dianova, Hamburg, Germany), 
qRT-PCR (Primer fw: 5’-accatcagcttgctacttgga-3’, rv: 
5’-acctgagtttttcagttctctcagt-3’) and DNA sequencing of 
CRISPR/Cas9 target region.  
Labeling  
Differentiated ER-HoxB8 cells (day 3) were 
harvested and labeled with DIR or DID, both 
available from ThermoFisher Scientific, Waltham, 
USA. 1x106 cells/mL were labeled with 98.7 µM 
DIR/EtOH or 47.5 µM DID/EtOH for 5 min and 
washed three times. Labeling efficiency was checked 
by flow cytometry (FL4-H), and viability by trypan 
blue or 7AAD staining. For in vivo FRI experiments, 
5x106 labeled cells/200 µL PBS were i.v. injected into 
the lateral tail vein of isoflurane-anesthetized mice. 
For MI experiments, harvested cells were incubated 
with 111In-Oxine (Mallinckrodt Deutschland, Hennef, 
Germany) at a concentration of approximately 1.2 
MBq/1x106 cells for 20 min at 37°C. Cells were 
washed once, resuspended in 100 µL saline/1x106 
cells and the amount of radioactivity was determined 
by scintillation counting (Wizard2, PerkinElmer, 
Waltham, USA). 10x106 labeled cells were i.v. injected 
1 day post coronary artery ligation. In some animals, 
the initial distribution of labeled cells was analyzed by 
dynamic SPECT imaging. For this purpose, mice were 
put under isoflurane anesthesia and a tail vein 
catheter was placed. Immediately after the scan was 
started, 5x106 cells in 100 µL saline were slowly 
injected over the course of 60 s. 
Viability 
Viability of cells was assessed by trypan blue 
staining or 7-aminoactinomycin D staining (Bio-
Legend, Fell, Germany) and subsequent flow 
cytometry analysis (FL3-H).  
Adhesion assay 
Cell adhesion was tested either on plastic surface 
or fibronectin coated surface. Differentiated (day 3) 
ER-HoxB8 cells were seeded (5x105 cells/well) onto 
untreated or fibronectin (FN; 25 µg/mL, Roche, 
Penzberg, Germany)-coated wells of a 24-well plate 
and allowed to adhere for 2 h at 37°C. After washing, 
remaining adherent cells were fixed with 2% 
glutaraldehyde, washed again and stained with 0.5% 
crystal violet (in 200 mM boric acid, pH 8). Cells were 
then lysed with 10% acetic acid and optical density 
was measured at 560 nm. 
Transmigration assay 
Spontaneous and chemokine-stimulated transm-
igration of differentiated ER-HoxB8 monocytes 
through a transwell filter was analyzed. 1x106 cells 
were applied to the upper chamber and no or 12 nM 
LTB4 (Biomol, Hamburg, Germany) was added to the 
lower chamber of the transwell filter system (5 µm 
pore size, ThermoFisher Scientific, Waltham, USA). 
Cells were allowed to migrate for 1 h at 37°C and cells 
migrated to the lower chamber were subsequently 
counted by flow cytometry (FSC/SSC).  
ROS production assay 
5x105 cells were stimulated with 100 nM phorbol 
myristate acetate (PMA, Abcam, Cambridge, UK) for 
1 h or left untreated. 15 µM dihydrorhodamine 123 
(DHR123, Sigma Aldrich, Munich, Germany) was 
added 15 min before the end of incubation. A 
subsequent washing step was followed by flow 
cytometry analysis (FL1-H).  
Phagocytosis assay 
The number of phagocytosing cells was 
determined by phagocytosis assay with fluorescently 
labeled beads. 5x105 cells were exposed to 5x106 beads 
(Fluospheres®Polystyrene Microspheres 1 µm, 530/ 
30 nm, ThermoFisher Scientific, Waltham, USA) for 4 
h at 37°C. After washing, cells were analyzed for 
fluorescent phagocytosed particles by flow cytometry 
(FL1-H).  
111In-Oxine retention 
111In-Oxine-labeled monocytes were incubated 
for 6, 24 or 48 h in 12-well plates (1×106 cells, labeled 
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with approximately 1 MBq, in 2 mL medium per 
well). At the respective time points, cells were 
harvested as described above and the amount of 
radioactivity in the cell pellet and supernatant was 
assessed by gamma counter measurement. 
Irritant contact dermatitis (ICD) 
Contact dermatitis [53] was induced by the 
application of 3% croton oil (Sigma Aldrich, Munich, 
Germany)/olive oil-acetone mixture (1:4) at the left 
ear (seen from the dorsal surface); the right ear served 
as control and was exposed to olive oil-acetone 
mixture (1:4) only. Ears were shaved beforehand. FRI 
measurements took place the next day, baseline, and 1 
h, 3 h, 6 h, 24 h after injection of labeled ER-HoxB8 
cells. At the end of the experiments, ears were 
processed as frozen sections (Tissue Tek, O.C.T.™ 
Compound, Cryomold®, Sakura, Alphen aan den 
Rijn, Netherlands). 
Cutaneous granuloma model (CG) 
As similarly described before [54], mice where 
shaved and 200 µL of Biogel (P-100, Bio Rad, 
Hercules, USA) was injected as a “plug” subcutan-
eously at both the right and the left flank, with the left 
one (seen from the dorsal surface) containing 20 
µg/200 µL lipopolysaccharide LPS (from Salmonella 
enterica serotype enteritidis, Sigma Aldrich, Munich, 
Germany) representing the inflammatory site and the 
right plug serving as control. FRI measurements were 
performed the next day, baseline, and 3 h, 6 h, 24 h, 30 
h, and 48 h after injection of labeled ER-HoxB8 cells. 
Optionally, plugs were isolated, transferred to PBS 
and homogenized through a 70 µm cell strainer 
(Corning®, Sigma Aldrich, Munich, Germany). 
Purified cells were analyzed by flow cytometry. 
Collagen-induced arthritis model (CIA) 
CIA was procured as previously described [49]. 
In short, mice were immunized by subcutaneous 
injection of 100 µg bovine collagen type II (bCII, MD 
Biosciences)/0.05 M acetic acid emulsified in 
Complete Freund’s Adjuvant (CFA; Sigma Aldrich) 
containing HKMT (4 mg/mL; InvivoGen) at the tail 
base of DBA/jdba1/j mice. 21 days later mice were 
optionally boosted i.p. with 100 µg bCII in IFA or left 
untreated. Animals were checked and scored for 
clinical symptoms at last 3 times a week, with disease 
scores ranging from 0-3/paw (S0 = no swelling; S1 = 
slight swelling of entire paw or one joint swollen; S2 = 
mild swelling of entire paw or more than one joint 
swollen; S3 = pronounced edematous swelling of 
entire paw or several joints or ankylosis). First signs of 
disease occurred around day 25 p.i. with animals 
reaching high disease scores (≥2) only a few days 
later. FRI measurements took place as mice showed 
clear clinical symptoms and were performed at 
baseline, and 1 h, 3 h, 6 h, and 24 h post injection of 
labeled ER-HoxB8 cells.  
Arthritis in IL1 Ra-/- mice 
Interleukin-1 receptor antagonist deficient 
(IL-1Ra-/-) mice will spontaneously develop an auto-
immune T cell-mediated arthritis in the hind paws 
due to excessive IL-1 signaling [55], TNF-α [56] and 
IL-17 signaling [57]. It is associated with increased 
infiltration of neutrophils and monocytes in the 
arthritic ankle joint [58]. 
Myocardial infarction 
Permanent ligation of the left anterior 
descending coronary artery was performed as 
described previously [59, 60]. Briefly, mice were i.p. 
injected with a mixture of Midazolam (4 mg/g 
bodyweight), Fentanyl (0.04 mg/g bodyweight) and 
Rimadyl (0.5 µL/g bodyweight) and kept under 
isoflurane anaesthesia and on a heating pad during 
surgery. Mice were intubated and ventilated using a 
Minivent ventilator. The left thorax was opened and 
the coronary artery permanently ligated with a suture 
(prolene 7.0). In sham operated animals, the suture 
was loosely placed without ligating the artery. The 
thorax (vicryl rapide 4.0) and skin (prolene 6.0) were 
closed with sutures before the animal was removed 
from the ventilator and allowed to recover on a 
heating pad. Food was provided on the cage floor for 
the first 48 h after surgery. 
FRI measurements 
In vivo imaging of labeled ER-HoxB8 cells by FRI 
in the ICD, the CG and the IL1RA-/- models was 
carried out using the IVIS Spectrum system 
(epi-illumination) by PerkinElmer, Waltham, USA 
(710 nm excitation/780 nm emission for DIR and 605 
nm/680 nm for DID). For imaging the CIA model, we 
employed the In-vivo MS FX PRO system 
(trans-illumination) by Bruker, Billerica, USA (730 
nm/790 nm for DIR). In both cases, mice were kept 
under anesthesia (DRÄGER Isofluran Vapor, Lübeck, 
Germany) and warm during the imaging process. 
For ICD and CG experiments, imaging analysis 
and quantification was carried out using Living 
Image®Software (PerkinElmer) and for CIA 
experiments using Bruker MI (Bruker). Therefore, 
ROIs (region of interest) were drawn around the ears, 
the plug zone and paws based on anatomical context 
(by white light images) to determine average radiant 
efficiency [p/s/cm2/sr]/[µW/cm2] (IVIS) and mean 
intensity AU (FX Pro), respectively. Data was then 
corrected for autofluorescence, labeling efficiency 
and, in the case of parallel injection of DIR and DID 
labeled cells (two color simultaneous imaging 
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approach), corrected for spectral overlap (compens-
ation). Therefore, a dilution series of DIR and DID 
labeled cells alone or in combination was included in 
every imaging experiment, allowing recalculation of 
received data. Fluorescence intensity AU (arbitrary 
units) was calculated as fluorescence intensity = [S(t) - 
S(0)]/ Fcolour (one color imaging approach) and as 
fluorescence intensity = [(S(t) - S(0)) x Fcompensation]/ Fcolour 
(two color simultaneous imaging approach),with S(t) 
being the fluorescence signal within a ROI at a time t 
post injection, S(0) the fluorescence signal within the 
ROI at baseline, Fcolor the correction factor for the 
labeling efficiency of cells and Fcompensation the 
correction factor for spectral overlap.  
SPECT Imaging 
SPECT experiments were carried out using a 
small-animal SPECT/CT scanner (nanoScan, Mediso, 
Budapest, Hungary). During all in vivo scans, mice 
were kept under isoflurane anesthesia and on a 
heated bed to maintain body temperature. The initial 
biodistribution of 111In-Oxine-labeled monocytes was 
assessed by dynamic whole-body SPECT scans (9x10 
min, FOV 100 mm) and static SPECT scans at 
approximately 3 h, 6 h, 24 h and 48 h post injection of 
cells (1×30 min, FOV 100 mm).  
Myocardial perfusion imaging was performed 
on the day of surgery to assess the area at risk. 60 MBq 
99mTc-Tetrofosmin in 100 µL was i.v. injected directly 
after closure of the thorax. Animals were then allowed 
to recover for one hour before undergoing static 
SPECT scanning of the thorax (1x30 min, FOV 26 mm) 
followed by native CT. On day 1 and day 2 p.i., the 
accumulation of monocytes in the infarct area was 
assessed by static thorax scans (1×60 min, FOV 26 
mm). Each scan was followed by a CT scan of the 
respective region. On day 2, 5 µL ExiTron nano 6000 
(Miltenyi Biotec, Bergisch Gladbach, Germany) per 
gram bodyweight was injected via a tail vein catheter 
2 min before the CT was started to better delineate the 
heart. 
SPECT images from cell tracking experiments 
were analyzed using in-house software MEDgical. 
To quantify cell migration in the CG model, 
volumes of interest (VOI) were drawn over the Biogel 
pellet based on CT images.  
For analysis of MI experiments, signal in the 
infarct zone was quantified by defining a VOI for the 
LV myocardium in contrast-enhanced CT. Area of 
infarction was defined as the part of the LV 
myocardium with < 25% maximum cardiac 
99mTc-Tetrofosmin uptake. Areas affected by spill-over 
artefacts induced by strong 99mTc-Tetrofosmin 
accumulation in the adjacent liver were excluded 
from analysis. Signal in the remote myocardium was 
quantified by placing an oval VOI in the septum, as 
this is a region spared from damage in coronary artery 
ligation in C57BL/6 mice [60]. Biodistribution of 
injected cells to other organs was analyzed by placing 
representative oval VOIs within the respective organs.  
All SPECT data from cell tracking experiments 
were corrected for radioactive decay, labeling 
efficiency and bodyweight by calculating mean 
standardized uptake units (SUVs) as SUV = [cimg(t) x 
BW]/ID, with cimg(t) being the concentration of 
radioactivity within a VOI at a time t post injection, 
decay corrected to t=0, and ID being the injected dose, 
i.e., the amount of radioactivity taken up by the 
injected cells.  
Autoradiography 
MI mice were sacrificed directly after the 48 h 
SPECT scan for ex vivo analysis. Following FRI 
measurements, the hearts were embedded in 
TissueTek® O.C.T.™ Compound (Sakura Finetek, 
Staufen, Germany) and snap-frozen at -20°C. 20 µm 
frozen sections were made and placed in a 
microimager (Micro-Imager V2, Biospace Lab, Nesles 
la Vallee, France) for 6 h to obtain autoradiographic 
images. Adjacent sections (10 µm) were collected for 
histological analysis. 
Scintillation counting 
Ex vivo radioactivity biodistribution was 
analyzed by scintillation counting (Wizard2 gamma 
counter, Perkin Elmer, Waltham, USA) and the 
radioactivity in respective organs was decay- 
corrected and expressed as percentage of injected 
dose per gram tissue (%ID/g). 
Histology 
Immunofluorescence staining 
Frozen sections of isolated mice ears were fixed 
in acetone and permeabilized with TBS/Triton x-100. 
Samples were washed, blocked and incubated with 
primary antibody α-GFP Alexa Fluor® 647 coupled 
(1:100, #A-31852, Thermo Fisher Scienific, Waltham, 
USA). After washing, an HRP-coupled secondary 
antibody was applied (goat-α-rabbit IgG, #111-036- 
045, Jackson Immuno Research, West Grove, USA). 
Samples were incubated in acetate buffer + 10% AEC 
(3-Amino-9-Ethylcarbazol) + 0.05% H2O2 to stain for 
peroxidase activity. Sections were counterstained 
with hematoxylin.  
For analysis by LI-COR® Odyssey® Imaging 
system, frozen sections were mounted with mounting 
medium (DAKO Fluorescence Mounting Medium, 
Real Carpinteria, USA). Sample analysis was carried 
out with LI-COR® Odyssey® Imaging system 
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(LI-COR® Biosciences, Nebraska, USA) using the 
filter set for 700 nm, 21 µm resolution. 
Tissue sections (7 µm) from formalin-fixed, 
paraffin-embedded ankle joints of IL-1Ra-/- mice were 
incubated for 2 h at RT in 10 mM citrate buffer (pH 
6.0) for antigen retrieval. Tissue sections were 
incubated overnight at 4°C with rabbit α-GFP (1:800, 
#2525, Cell Signaling, Danvers, MA, USA) for staining 
of infiltrated GFP+ ER-HoxB8 cells. Sections were 
incubated with biotinylated goat anti-rabbit IgG as a 
second antibody followed by incubation with 
avidin-streptavidin-peroxidase (VECTASTAIN, Elite 
ABC HRP kit, Vector, Burlingame, USA). Peroxidase 
activity was stained with 3,3’-diaminobenzidine (DAB, 
Powervision DAB, Immunologic, Duiven, the 
Netherlands) in the presence of H2O2 and all sections 
were counterstained with hematoxylin. 
Mac-3 immunohistochemistry on MI hearts was 
performed by first demasking in citrate buffer and 
blocking with peroxidase blocking solution. Slides 
were washed and incubated with primary antibody 
(1:50, Mac-3 Rat IgG1, #550292 BD Biosciences, 
Franklin Lakes, USA), followed by washing and 
incubation with secondary antibody (biotinylated 
mouse anti-rat, #550325 BD Biosciences, Franklin 
Lakes, US). After washing, slides were incubated with 
streptavidin (DAKO, Hamburg, Germany), followed 
by DAB solution (Sigma-Aldrich, St. Louis, USA, 49 
mL PBS, 1 mL DAB, 20 mL H2O2) and counterstaining 
with hematoxylin. Slides were then dehydrated and 
covered with entellan. 
Flow cytometry analysis 
Analyzed cells were gated for viability, i.e., dead 
cells were discriminated by FSC/SSC. 
Statistical analysis 
Statistical significance was analyzed by paired or 
unpaired two-sided Student’s t-test or Kruskal-Wallis 
Analysis and Dunn’s Multiple Comparison or 2-way 
ANOVA and Bonferroni post-tests. P-values of 
p*<0.05, p**<0.01 and p***<0.001 were considered to 
be significant. Size of experimental groups was 
estimated according to the method Cohen’s D for 
detection of medium effect sizes. 
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